Metagenomi Stock (NASDAQ: MGX) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 137.151K |
Day Range | - - - |
52 Wk Range | 5.500 - 12.740 |
Market Cap | $262.306M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 44 |
Short Interest | 2.62% |
Days to Cover | 5.1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Metagenomi (NASDAQ: MGX) through any online brokerage.
Other companies in Metagenomi’s space includes: Zura Bio (NASDAQ:ZURA), Inozyme Pharma (NASDAQ:INZY), Opthea (NASDAQ:OPT), Monte Rosa Therapeutics (NASDAQ:GLUE) and Century Therapeutics (NASDAQ:IPSC).
The latest price target for Metagenomi (NASDAQ: MGX) was reported by HC Wainwright & Co. on Wednesday, May 15, 2024. The analyst firm set a price target for 10.00 expecting MGX to rise to within 12 months (a possible 42.86% upside). 10 analyst firms have reported ratings in the last year.
The stock price for Metagenomi (NASDAQ: MGX) is $7 last updated May 16, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Metagenomi.
Metagenomi’s Q2 earnings are confirmed for Monday, August 12, 2024.
There is no upcoming split for Metagenomi.
Metagenomi is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.